Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial-Reference-Cited by-同舟云学术

Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial

Published:2022-07-12 Issue:10 Volume:20 Page:1341-1350
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Elshafie Ahmed Hanei¹,Elsawah Hozaifa Khalil²,Hammad Mohamed¹,Sweed Eman Mohamed³^ORCID,Seif Ahmed Salah⁴,Abdel Ghaffar Muhammad Mostafa⁵,Goda Feisal Mahmoud⁶,Mosalam Esraa M⁷,Abdallah Mahmoud S.⁸^ORCID

Affiliation:

1. Neurology and Psychiatry Department, Shebin Elkom Teaching Hospital, Menoufia University, Shebin Elkom, Egypt

2. Department of Biostatistics, High Institute of Public Health, Alexandria University, Alexandria, Egypt

3. Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Shebin Elkom, Egypt

4. Gastrohepatology and Endemic Medicine Department, Shebin Elkom Teaching Hospital, Menoufia University, Shebin Elkom, Egypt

5. Gastrohepatology and Endemic Medicine Department, Ahmed Maher Teaching Hospital, Cairo, Egypt

6. General Surgery Department, Shebin Elkom Teaching Hospital, Menoufia University, Shebin Elkom, Egypt

7. Department of Biochemistry, Faculty of Pharmacy, Menoufia University, Shebin El-Kom, Egypt

8. Clinical Pharmacy Department, Faculty of Pharmacy, University of Sadat City (USC), Sadat City, Egypt

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2022.2098113

Reference46 articles.

1. Current Status of COVID-19 Therapies and Drug Repositioning Applications

2. Woldometers. COVID-19 coronavirus pandemic; 2022 [cited 2022 Jan 8]. Available from: https://www.worldometers.info/coronavirus

3. Predictors of COVID-19 severity: a systematic review and meta-analysis

4. COVID ‐19: immunopathology, pathophysiological mechanisms, and treatment options

5. Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma